| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |